Equivalent Impact of Elevated Lipoprotein(a) and Familial Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease

Lipoprotein(a) as Part of the Diagnosis of Clinical Familial Hypercholesterolemia

(2022) Anne Langsted et al.   Current Atherosclerosis Reports

Effect of Pelacarsen on Lipoprotein(a) Cholesterol and Corrected Low-Density Lipoprotein Cholesterol

(2022) Calvin Yeang et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult

(2021) Glen J. Pearson et al.   CANADIAN JOURNAL OF CARDIOLOGY

Forty-Year Anniversary of Arteriosclerosis, Thrombosis, and Vascular Biology

(2021) Alan Daugherty et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association

(2021) Gissette Reyes-Soffer et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Familial hypercholesterolaemia: history, diagnosis, screening, management and challenges

(2020) Erik Berg Schmidt et al.   HEART

Lipoprotein(a) and Cardiovascular Disease

(2020) Pia R Kamstrup   CLINICAL CHEMISTRY

Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among Seven Ethnic Groups

(2019) Guillaume Paré et al.   CIRCULATION

How to identify familial premature myocardial infarction: comparing approaches to identify familial hypercholesterolemia

(2019) Sabina Beheshti et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Use of lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association. Don P. Wilson, MD, on behalf of the Writing group

(2019) Don P. Wilson et al.   Journal of Clinical Lipidology

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

(2019) François Mach et al.   EUROPEAN HEART JOURNAL

Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities

(2019) A. Vuorio et al.   JOURNAL OF INTERNAL MEDICINE

NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis

(2018) Sotirios Tsimikas et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Advances in lipid-lowering therapy through gene-silencing technologies

(2018) Børge G. Nordestgaard et al.   Nature Reviews Cardiology

Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies

(2018) Stephen Burgess et al.   JAMA Cardiology

High lipoprotein(a) and high risk of mortality

(2018) Anne Langsted et al.   EUROPEAN HEART JOURNAL

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

(2017) Brian A. Ference et al.   EUROPEAN HEART JOURNAL

A Test in Context: Lipoprotein(a)

(2017) Sotirios Tsimikas   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

FRANK E. HARRELL, Jr., Regression Modeling Strategies: With Applications, to Linear Models, Logistic and Ordinal Regression, and Survival Analysis, 2nd ed. Heidelberg: Springer.

(2016) E. W. Steyerberg   BIOMETRICS

Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217

(2016) Marianne Benn et al.   EUROPEAN HEART JOURNAL

Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology

(2016) Børge G. Nordestgaard et al.   JOURNAL OF LIPID RESEARCH

High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study

(2016) Anne Langsted et al.   Lancet Diabetes & Endocrinology

Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment

(2015) Albert Wiegman et al.   EUROPEAN HEART JOURNAL

Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia

(2015) Dick C. Chan et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

The Danish National Patient Registry: a review of content, data quality, and research potential

(2015) Morten Schmidt et al.   Clinical Epidemiology

Lipoprotein(a) Levels in Familial Hypercholesterolemia

(2014) Rodrigo Alonso et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society

(2013) B. G. Nordestgaard et al.   EUROPEAN HEART JOURNAL

Lipoprotein(a): resurrected by genetics

(2013) F. Kronenberg et al.   JOURNAL OF INTERNAL MEDICINE

Associations Between Lipoprotein(a) Levels and Cardiovascular Outcomes in Black and White Subjects

(2011) Salim S. Virani et al.   CIRCULATION

The Danish Register of Causes of Death

(2011) Karin Helweg-Larsen   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

Lipoprotein(a) as a cardiovascular risk factor: current status

(2010) Børge G. Nordestgaard et al.   EUROPEAN HEART JOURNAL